XML 20 R3.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 86,952 $ 62,838
Accounts receivable, net 47,682 30,529
Inventories 12,158 10,998
Prepaid expenses 3,349 5,700
Other current assets 1,201 2,356
Total current assets 151,342 112,421
Property and equipment, net 3,222 2,087
Operating lease right-of-use assets 7,185 5,763
Intangible assets, net 48,754 47,110
Goodwill 21,208 21,208
Other assets 858 409
Total assets 232,569 188,998
Current Liabilities    
Accounts payable 9,236 4,271
Accrued expenses 40,791 33,813
Operating lease liabilities 1,718 1,377
Contingent royalty obligation payable to Evolus Founders 11,215 8,830
Total current liabilities 62,960 48,291
Operating lease liabilities 6,755 4,810
Contingent royalty obligation payable to Evolus Founders 33,550 36,200
Term loan, net of discount and issuance costs 121,506 120,359
Contingent milestone payment 2,270 0
Deferred tax liability 6 27
Total liabilities 227,047 209,687
Commitments and contingencies (Note 9)
Stockholders’ equity (deficit)    
Preferred Stock, $0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at December 31, 2024 and 2023, respectively 0 0
Common Stock, $0.00001 par value; 100,000,000 shares authorized; 63,497,548 and 57,820,621 shares issued and outstanding at December 31, 2024 and 2023, respectively 1 1
Additional paid-in capital 615,825 538,716
Accumulated other comprehensive loss (905) (427)
Accumulated deficit (609,399) (558,979)
Total stockholders’ equity (deficit) 5,522 (20,689)
Total liabilities and stockholders’ equity (deficit) $ 232,569 $ 188,998